ATE251142T1 - Eine kristallmodifikation von celecoxib - Google Patents

Eine kristallmodifikation von celecoxib

Info

Publication number
ATE251142T1
ATE251142T1 AT01106333T AT01106333T ATE251142T1 AT E251142 T1 ATE251142 T1 AT E251142T1 AT 01106333 T AT01106333 T AT 01106333T AT 01106333 T AT01106333 T AT 01106333T AT E251142 T1 ATE251142 T1 AT E251142T1
Authority
AT
Austria
Prior art keywords
celecoxib
crystal modification
ylübenzenesulfo
namide
pyrazol
Prior art date
Application number
AT01106333T
Other languages
English (en)
Inventor
Halit Guenduez
Mehmet Bahar
Mehmet Goektepe
Original Assignee
Fako Ilaclari A S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fako Ilaclari A S filed Critical Fako Ilaclari A S
Application granted granted Critical
Publication of ATE251142T1 publication Critical patent/ATE251142T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
AT01106333T 2000-06-26 2001-03-15 Eine kristallmodifikation von celecoxib ATE251142T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2000/01872A TR200001872A2 (tr) 2000-06-26 2000-06-26 4-[5-(4-Metilfenil-3-(triflorometil)-1H-pirazol-1-il] benzensulfonamit' in yeni kristal biçimi "Biçim I" ve bu ürünün üretilmesine ilişkin yöntem.

Publications (1)

Publication Number Publication Date
ATE251142T1 true ATE251142T1 (de) 2003-10-15

Family

ID=21622570

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01106333T ATE251142T1 (de) 2000-06-26 2001-03-15 Eine kristallmodifikation von celecoxib

Country Status (13)

Country Link
US (1) US6391906B2 (de)
EP (1) EP1167355B1 (de)
AT (1) ATE251142T1 (de)
AU (1) AU2001276808A1 (de)
CA (1) CA2350956C (de)
DE (1) DE60100873T2 (de)
EA (1) EA004470B1 (de)
ES (1) ES2206360T3 (de)
HK (1) HK1045155B (de)
IL (1) IL153615A0 (de)
PT (1) PT1167355E (de)
TR (1) TR200001872A2 (de)
WO (1) WO2002000627A1 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA74539C2 (en) * 1999-12-08 2006-01-16 Pharmacia Corp Crystalline polymorphous forms of celecoxib (variants), a method for the preparation thereof (variants), a pharmaceutical composition (variants)
DE10135027A1 (de) * 2001-07-18 2003-02-06 Solvay Pharm Gmbh Verwendung Trifluoracetylalkyl-substituierter Phenyl-, Phenol- und Benzoylderivate in der Behandlung und/oder Prophylaxe von Obestias und deren Begleit- und/oder Folgeerkrankungen
WO2003024958A2 (en) 2001-09-18 2003-03-27 Onconova Therapeutics, Inc. Processes for the preparation of 1,5-diaryl-3-substituted-pyrazoles
AU2002330042A1 (en) 2001-09-18 2003-04-01 Onconova Therapeutics, Inc. Process for the preparation of 1,5-diarylpyrazoles
US7927613B2 (en) 2002-02-15 2011-04-19 University Of South Florida Pharmaceutical co-crystal compositions
US20030224006A1 (en) 2002-03-01 2003-12-04 Zaworotko Michael J. Multiple-component solid phases containing at least one active pharmaceutical ingredient
WO2004061433A1 (en) * 2002-12-30 2004-07-22 Transform Pharmaceuticals, Inc. Pharmaceutical compositions with improved dissolution
US7790905B2 (en) 2002-02-15 2010-09-07 Mcneil-Ppc, Inc. Pharmaceutical propylene glycol solvate compositions
WO2003090730A1 (en) * 2002-04-25 2003-11-06 Generics [Uk] Limited Novel crystalline forms of celecoxib and other compounds
WO2003091221A1 (en) * 2002-04-25 2003-11-06 Generics [Uk] Limited Celecoxib forms
MXPA04011654A (es) * 2002-05-24 2005-03-07 Pharmacia Corp Sintesis de diarilpirazoles.
EP1515703A1 (de) 2002-06-21 2005-03-23 Transform Pharmaceuticals, Inc. Pharmazeutische zusammensetzungen mit verbesserter auflösung
US8183290B2 (en) 2002-12-30 2012-05-22 Mcneil-Ppc, Inc. Pharmaceutically acceptable propylene glycol solvate of naproxen
DK1742922T3 (en) * 2004-04-01 2016-04-11 Zoetis Services Llc crystalline pyrazole
WO2006024930A1 (en) * 2004-09-01 2006-03-09 Pharmacia & Upjohn Company Llc Novel co-crystals between polyethylene glycols and 5-phenylpyrazolyl-1-benzenesulfonamides
CN101048510B (zh) * 2004-10-28 2013-07-10 帝斯曼知识产权资产管理有限公司 游霉素的稳定针形晶体
EP1846377A2 (de) * 2005-01-31 2007-10-24 Pharmacia & Upjohn Company LLC Kristallines form-iv-celecoxib
CA2686830C (en) * 2007-05-25 2015-09-08 Exxonmobil Upstream Research Company A process for producing hydrocarbon fluids combining in situ heating, a power plant and a gas plant
WO2011055233A2 (en) 2009-11-03 2011-05-12 Actavis Group Ptc Ehf Improved process for preparing celecoxib polymorph
US20110213159A1 (en) * 2010-03-01 2011-09-01 Vamsee Krishna Muppidi Process for preparation of celecoxib crystalline form
CN103524416B (zh) * 2013-10-29 2016-08-17 湖北华世通生物医药科技有限公司 一种塞来昔布新晶型a及其制备方法
CN103539739B (zh) * 2013-10-30 2016-02-10 中美华世通生物医药科技（武汉）有限公司 一种塞来昔布新晶型b及其制备方法
CN103508958A (zh) * 2013-10-30 2014-01-15 中美华世通生物医药科技（武汉）有限公司 一种塞来昔布新晶型c及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5604260A (en) 1992-12-11 1997-02-18 Merck Frosst Canada Inc. 5-methanesulfonamido-1-indanones as an inhibitor of cyclooxygenase-2
NZ336428A (en) * 1993-11-30 2005-02-25 G use of substituted pyrazolyl benzosulphonamides to treat inflammation
RU2169143C2 (ru) * 1995-05-25 2001-06-20 Джи. Ди. Сирл Энд Ко. Способ получения 3-галогеналкил-1н-пиразолов
CA2360354A1 (en) * 1999-01-14 2000-07-20 Sophie-Dorothee Clas Synthesis of 4-[(5-substituted or unsubstituted phenyl)-3-substituted-1h-pyrazol-1-yl] benzenesulfonamides
UA74539C2 (en) * 1999-12-08 2006-01-16 Pharmacia Corp Crystalline polymorphous forms of celecoxib (variants), a method for the preparation thereof (variants), a pharmaceutical composition (variants)

Also Published As

Publication number Publication date
EP1167355A1 (de) 2002-01-02
DE60100873T2 (de) 2004-07-22
ES2206360T3 (es) 2004-05-16
HK1045155A1 (en) 2002-11-15
HK1045155B (zh) 2004-05-28
US20020016351A1 (en) 2002-02-07
TR200001872A3 (tr) 2002-01-21
DE60100873D1 (de) 2003-11-06
EA004470B1 (ru) 2004-04-29
EA200300067A1 (ru) 2003-06-26
CA2350956A1 (en) 2001-12-26
WO2002000627A1 (en) 2002-01-03
EP1167355B1 (de) 2003-10-01
TR200001872A2 (tr) 2002-01-21
PT1167355E (pt) 2004-02-27
IL153615A0 (en) 2003-07-06
US6391906B2 (en) 2002-05-21
AU2001276808A1 (en) 2002-01-08
CA2350956C (en) 2005-08-23

Similar Documents

Publication Publication Date Title
DE60100873D1 (de) Eine kristallmodifikation von Celecoxib
DK0931788T3 (da) Metalloproteasehæmmere
ECSP055594A (es) Nuevos derivados de 2-piridiletilbenzamida
ATE308536T1 (de) 4-alkylsubstituierte thienyloxy-pyrididne als herbizide
DK1218372T3 (da) Nye heterocykliske forbindelser, der er anvendelige som reversible inhibitorer af cysteinproteaser
SE0100902D0 (sv) Compounds
FI904327A0 (fi) N-substituerad-4-pyrimidinaminer och -pyrimidindiaminer, foerfarande foer deras framstaellning och deras anvaendning som laekemedel.
ATE332130T1 (de) Fab-i-hemmer
AP2001002205A0 (en) Cyclopentyl-substituted glutaramide derivatives as inhibitors of neutral endopeptidase.
EA200400414A1 (ru) Кристаллические гидраты производных анилида никотиновой кислоты
EA200501226A1 (ru) Новая кристаллическая модификация негидратированного боскалида
BR0211652B1 (pt) compostos de piridona e processo para produÇço de composto de piridina.
ATE360012T1 (de) Heterozyklische carboxamide und ihre verwendung als fungizide
AR008287A1 (es) Composicion herbicida que comprende compuestos de pirazol sustituidos y metodo de aplicacion de los mismos
MA26299A1 (fr) Procede pour la surveillance et le controle des thysanopteres
BR0009453B1 (pt) processo para a preparação de um composto.
EP1626047A4 (de) Verfahren zur herstellung eines substituierten aminochinazolinonderivats, zwischenprodukt dafür, und schädlingsbekämpfungsmittel
TR200402776T4 (tr) Nöraminik asit bileşiğinin hidratları ve bunların kristal biçimleri.
ATE348800T1 (de) 4'-methansulfonylbiphenylderivate als hochselektive cyclooxygenase-2-inhibitoren
DE60103129D1 (de) Benzofurancarboxamide und deren therapeutische verwendung
DK1637141T3 (da) Stabiliseret proteasesammensætning omfattende en serinprotease, morpholinderivater og reversible inhibitorer af serinproteasen
DK0475352T3 (da) 3-(1H-Indazol-3-yl)-4-pyridinaminer, fremgangsmåde og mellemprodukter til deres fremstilling og deres anvendelse som lægemidler
EA200100601A1 (ru) Производные 3-(гетероциклил) бензоилпиразолов
DK0979822T3 (da) Fremgangsmåde til fremstilling af 2-carbamoyl-pyridiner
NO20025101L (no) Nye, heterosykliske forbindelser med antiinflammatorisk aktivitet

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties